SCHEMBL7307983

SCHEMBL7307983

CN1CCN(CCOc2ncc(Cl)cc2Cl)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
SIGMAR1 Q99720 5/20 0.45
KCNH2 Q12809 1/20 0.45
CXCR1 P25024 1/20 0.44
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
MCHR1 Q99705 1/20 0.43
CYP2C9 P11712 2/20 0.41
TSHR P16473 1/20 0.41
APEX1 P27695 1/20 0.41
AIMP2 Q13155 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 1/20 0.40
TMEM97 Q5BJF2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7296366 0.88 LTA4H (0.48) KDM4ESIGMAR1LMNASMN1; SMN2CYP2C9
SCHEMBL7298308 0.87 TSHR (0.50) KDM4ESIGMAR1TSHRPOLBLTA4H
SCHEMBL7300773 0.84 TSHR (0.57) KDM4EALDH1A1SIGMAR1KCNH2HTT
SCHEMBL8342490 0.84 KDM4E (0.47) KDM4EALDH1A1SIGMAR1LMNASMN1; SMN2
SCHEMBL16815394 0.73 MEN1 (0.42) MEN1KMT2AKDM4EALDH1A1SIGMAR1
Hydrochloric Acid SCHEMBL7298155 0.73 ALDH1A1 (0.50) MEN1KMT2AKDM4EALDH1A1SIGMAR1
SCHEMBL8983549 0.73 SMN1; SMN2 (0.55) ALDH1A1LMNASMN1; SMN2MAPK1CYP2C9
SCHEMBL11882534 0.72 LMNA (0.53) KDM4ELMNASMN1; SMN2MAPK1CYP2C9
SCHEMBL26660592 0.72 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1SIGMAR1
SCHEMBL29284151 0.71 MEN1 (0.46) MEN1KMT2AKDM4EALDH1A1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0550111-B1 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them SANOFI SA (FR) 1999-04-14 EP disclosed
US-5652254-A TREATMENT OF DEGENERATIVE DISEASES, RHEUMATOID ARTHRITIS, PSORIASIS, CYSTIC FIBROSIS SANOFI, S.A. (FR) 1997-07-29 US disclosed
US-5563163-A TREATMENT OF DEGENERATIVE DISEASES STERLING WINTHROP, INC. (US) 1996-10-08 US disclosed
US-5488062-A 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof STERLING WINTHROP INC. (US) 1996-01-30 US disclosed
US-5376653-A A protease enzyme inhibitor for treating degenerative diseases , respiratory system disorders, rheumatoid arthritis and pancreatitis STERLING WINTHROP INC. (US) 1994-12-27 US disclosed
EP-0550111-A1 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them STERLING WINTHROP INC. (US) 1993-07-07 EP disclosed